| pubmed-article:10704552 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C0031740 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C0740422 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C0002978 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C1299003 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C0338310 | lld:lifeskim |
| pubmed-article:10704552 | lifeskim:mentions | umls-concept:C1518316 | lld:lifeskim |
| pubmed-article:10704552 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10704552 | pubmed:dateCreated | 2000-4-4 | lld:pubmed |
| pubmed-article:10704552 | pubmed:abstractText | To investigate the suitability of lutetium texaphyrin (lu-tex) as a fluorescence imaging agent in the delineation of retinal vascular and choroidal vascular diseases. The utilization of an efficient fluorescent molecule that is also a photosensitizer represents a unique opportunity to couple diagnosis and therapy. | lld:pubmed |
| pubmed-article:10704552 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10704552 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10704552 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10704552 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10704552 | pubmed:issn | 0002-9394 | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:MillerRR | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:KesselDD | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:BlumenkranzM... | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:QingFF | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:WoodburnK WKW | lld:pubmed |
| pubmed-article:10704552 | pubmed:author | pubmed-author:VerdoonerSS | lld:pubmed |
| pubmed-article:10704552 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10704552 | pubmed:volume | 129 | lld:pubmed |
| pubmed-article:10704552 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10704552 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10704552 | pubmed:pagination | 353-62 | lld:pubmed |
| pubmed-article:10704552 | pubmed:dateRevised | 2010-3-23 | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:meshHeading | pubmed-meshheading:10704552... | lld:pubmed |
| pubmed-article:10704552 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10704552 | pubmed:articleTitle | Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. | lld:pubmed |
| pubmed-article:10704552 | pubmed:affiliation | Pharmacyclics Inc, Sunnyvale, CA, USA. mu.msb@forsythe.stanford.edu | lld:pubmed |
| pubmed-article:10704552 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10704552 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10704552 | lld:pubmed |
